Conditions: Gastric Neoplasms; Gastroesophageal Junction Adenocarcinoma
Interventions: Biological: Pembrolizumab; Drug: Paclitaxel
Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting - verified January 2017
ERC Advanced Grant to three researchers at Karolinska Institutet - Three researchers at Karolinska Institutet have been awarded the ERC Advanced Grant 2016 from the European Research Council. The three researchers who rece...